Yaso Therapeutics
Phase 1Our patented drug, PPCM, shows broad activity against viral and bacterial pathogens, with the potential to prevent and treat drug-resistant strains. That’s important for stopping the spread of STDs, worldwide. Yaso Gel works at the nanoscale. PPCM creates a barrier that surrounds viruses, stopping them before they can infect cells. By harnessing nanotechnology, Yaso delivers a new generation of protection.
About
Our patented drug, PPCM, shows broad activity against viral and bacterial pathogens, with the potential to prevent and treat drug-resistant strains. That’s important for stopping the spread of STDs, worldwide. Yaso Gel works at the nanoscale. PPCM creates a barrier that surrounds viruses, stopping them before they can infect cells. By harnessing nanotechnology, Yaso delivers a new generation of protection.
Funding History
1Total raised: $4.5M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile